Results 121 to 130 of about 10,573,620 (195)

The Clinical Efficacy of Imiglucerase versus Eliglustat in Patients with Gaucher's Disease Type 1: A Systematic Review. [PDF]

open access: yesJ Res Pharm Pract, 2018
Nabizadeh A   +7 more
europepmc   +1 more source

Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease.

open access: yesBrain : a journal of neurology, 2012
Einat. B. Vitner   +4 more
semanticscholar   +1 more source

AAV delivery of GBA1 suppresses α-synuclein accumulation in Parkinson's disease models and restores functions in Gaucher's disease models. [PDF]

open access: yesPLoS One
Okai T   +9 more
europepmc   +1 more source

Beta Thalassemia Major with Gaucher's Disease: A Rare Entity. [PDF]

open access: yesCureus, 2019
Bai N   +4 more
europepmc   +1 more source

Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease. [PDF]

open access: yesOrphanet J Rare Dis, 2020
Andrade-Campos MM   +9 more
europepmc   +1 more source

Macitentan in the treatment of pulmonary hypertension in Gaucher's disease

open access: yesAnatolian Journal of Cardiology, 2020
Gokay Taylan   +3 more
doaj   +1 more source

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease.

open access: yesNew England Journal of Medicine, 1993
T. Starzl   +11 more
semanticscholar   +1 more source

[Clinical features and genetic manifestations of two families with Gaucher's disease]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2019
Li SJ, Zheng WW, Sun MY, Qi JY, Jiang B.
europepmc   +1 more source

Muscle-tendon weakness contributes to chronic fatigue syndrome in Gaucher's disease. [PDF]

open access: yesJ Orthop Surg Res, 2019
Roca-Espiau M   +6 more
europepmc   +1 more source

Gaucher Disease and Gaucher Cells

open access: yesTurkish Journal of Hematology, 2015
openaire   +2 more sources

Home - About - Disclaimer - Privacy